PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H...

PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue. This five-year initiative will scale cell manufacturing and biofabrication to create on-demand organs from a patient’s own cells. By integrating programmable bioresorbable platforms, the program shifts the industry from anatomical models to functional, immunocompetent organ production. This investment marks a systemic move toward solving organ shortages via additive manufacturing. 🏥🧬 #bioprinting #additivemanufacturing #medtech #regenerativemedicine